Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening

Aragaw Gebeyehu,Sunil Kumar Surapaneni,John Huang,Arindam Mondal,Vivian Ziwen Wang,Nana Fatima Haruna,Arvind Bagde,Peggy Arthur,Shallu Kutlehria,Nil Patel,Arun K. Rishi,Mandip Singh
DOI: https://doi.org/10.1038/s41598-020-79325-8
IF: 4.6
2021-01-11
Scientific Reports
Abstract:Abstract A series of stable and ready-to-use bioinks have been developed based on the xeno-free and tunable hydrogel (VitroGel) system. Cell laden scaffold fabrication with optimized polysaccharide-based inks demonstrated that Ink H4 and RGD modified Ink H4-RGD had excellent rheological properties. Both bioinks were printable with 25–40 kPa extrusion pressure, showed 90% cell viability, shear-thinning and rapid shear recovery properties making them feasible for extrusion bioprinting without UV curing or temperature adjustment. Ink H4-RGD showed printability between 20 and 37 °C and the scaffolds remained stable for 15 days at temperature of 37 °C. 3D printed non-small-cell lung cancer (NSCLC) patient derived xenograft cells (PDCs) showed rapid spheroid growth of size around 500 μm in diameter and tumor microenvironment formation within 7 days. IC 50 values demonstrated higher resistance of 3D spheroids to docetaxel (DTX), doxorubicin (DOX) and erlotinib compared to 2D monolayers of NSCLC-PDX, wild type triple negative breast cancer (MDA-MB-231 WT) and lung adenocarcinoma (HCC-827) cells. Results of flow property, shape fidelity, scaffold stability and biocompatibility of H4-RGD suggest that this hydrogel could be considered for 3D cell bioprinting and also for in-vitro tumor microenvironment development for high throughput screening of various anti-cancer drugs.
multidisciplinary sciences
What problem does this paper attempt to address?